Let’s Talk Healthcare

The best way to understand the impact of digital media is active, two-way participation. We welcome you to participate in our GCI Health blog and add to our conversation on the various trends and complex issues within healthcare communication.

Leading Thoughts

  • April 11, 2018
    • Comments Off on GCI Health has been Shortlisted for Midsize Agency of the Year by the Holmes Report

    GCI Health has been Shortlisted for Midsize Agency of the Year by the Holmes Report

    GCI Health has been nominated or named Healthcare Agency of the Year for the last seven years. This year, we are extremely honored to be recognized as Midsize Agency of the Year. The winners will be announced at the SABRE awards on May 1st.  The write-up that appeared on the Holmes Report website follows:

    GCI Health (WPP)

    Still only 10 years old, GCI Health has established itself not only as one of the best healthcare PR firms in the US — it won Healthcare Agency of the Year last year — but one of the best midsize agencies of any kind. Another year of 25% revenue growth brings the firm close to the $50 million mark, and GCI now has a team of 160 people globally—more than 140 of those in the North American market. New business came from Abbott’s nutrition and diabetes care divisions, Bristol Myers Squibb, and a number of new Pfizer brands — GCI now works for eight of the top 10 global pharma companies — and smaller passion projects like Cohen Veterans Bioscience, which is helping veterans address PTSD.

    At the heart of the agency’s success is the patient-centric approach it developed three years ago, which uses both traditional research and its own immersion in client communities to understand consumers’ whole lives, not just their conditions or treatments. That has led to some innovative work in the sector, whether it’s a corporate storytelling campaign for Pfizer humanizing its CSR work fighting neglected tropical diseases; an influencer-driven strategy for device-maker Abbott and its Freestyle Libre diabetes technology; an unusual media partnership with IHeartRadio to encourage patients to “tune into AFib” for BMS/Pfizer. The firm also has its own media partnership — with Redbook — promoting women’s health.

    As should be evident from all that, GCI Health is a very “mission-driven” company — something that global CEO Wendy Lund and president of North America Kristin Cahill have continuously encouraged — resulting in one of the lowest employee turnover rates in the industry and regular appearances on our Best Agencies to Work For lists, voted on by employees. — PH

  • November 16, 2017
    • Comments Off on Wendy Lund Named to MM&M/PRWeek’s 50 Top Health Influencers

    Wendy Lund Named to MM&M/PRWeek’s 50 Top Health Influencers

    For the second year in a row, Wendy Lund, CEO, GCI Health, has been named to MM&M/PRWeek’s 50 Top Health Influencers. According to Mark Iskowitz, editor in chief of MM&M, “Nearly all facets of the healthcare industry are either being disrupted, or are, as they say, ripe for disruption. And these 50 seasoned executives possess the essential qualities needed to capitalize on the seismic shifts.”

    This year’s list recognizes 50 of the biggest players from among hundreds of professionals considered across the biopharma, agencies and government sectors, and among them many of the most essential executives in healthcare marketing. To be an influencer takes prescience to anticipate transformative trends. The next ingredient is perspective, to recognize when the time is right for biotech, pharma, and medtech companies to embrace the new. Last, but not least, an influencer must have the persuasiveness to get others to follow suit.

    Mike Hudnall, CEO of WPP Health & Wellness provided the below profile on Wendy featured on the Health Influencer site:

    Passion, conviction, tenacity, and achievement are probably the hallmarks of Wendy’s leadership style. Over her 30-plus year career, Wendy’s innate drive to push boundaries, find the better way, and champion gender equality have made an indelible mark across the WPP network, client organizations, and health communications.

    In our increasingly dynamic industry, effective, visionary leadership is mandatory, and Wendy brings that and so much more to the table. On her watch, GCI Health has quadrupled revenue, exponentially increased its client base, expanded its European footprint, and cemented its reputation as a leader in the healthcare PR space.

    Wendy’s commitment to people, including peers, employees, clients, and female business leaders, is one of the key attributes that sets her apart. She’s actively nurtured an environment of collaboration, innovation, and inclusion that yields impressive results. Wendy embodies many of WPP Health & Wellness’ core values, and I am honored to count her among our closest network partners.

  • October 5, 2017
    • Comments Off on Wendy Lund, CEO, Featured in O’Dwyer’s Healthcare and Medical PR Magazine

    Wendy Lund, CEO, Featured in O’Dwyer’s Healthcare and Medical PR Magazine

    This blog post by Craig Heit

    Wendy Lund, CEO, GCI Health, developed a feature article “Communicating in Chaotic Times” for O’Dwyer’s Healthcare and Medical PR Magazine. This piece focuses on how to break through with a brand’s message in today’s disruptive media environment.


  • July 31, 2017
    • Comments Off on Communicating in Chaotic Times by Wendy Lund, CEO

    Communicating in Chaotic Times by Wendy Lund, CEO

    Breaking through with your messages in today’s media environment is tough, and the healthcare industry is certainly not immune to the changes to newsrooms we’ve seen in the last few years. Given these challenges, the 13th ExL Pharma Public Relations & Communications Summit, one of the largest gatherings of communications professionals in the pharmaceutical space, set out to explore these obstacles and provide best practices to overcome them and ensure key audiences are reached. Over the course of two days of presentations and robust discussions with peers and experts in the space, attendees focused on the myriad challenges communicators face and how quickly and nimbly our industry is able to adapt to “get the job done.”

    For the sixth year in a row, GCI Health served as marquee sponsor for the Summit. This year, I was honored to serve as conference co-chair, the first agency person to ever serve in this capacity, and played a key role in helping to shape the theme of this year’s meeting, “Providing a Clear Path Forward During Chaotic Times.” Four key points coming out of the Summit stuck with me.

    Combatting Fake News. Fake news is very topical today, particularly as it relates to our government, but in healthcare, the pharmaceutical industry has been living with it for a long time. The stakes here are huge and the industry has to get a handle on the flow of information to protect not only their companies, but the patients they serve. Efforts to combat fake news and maintain trust need to center on creating credible content, keeping ahead of trends and issues as they emerge and (quickly) countering inaccurate information.

    Breaking Through With Your Story. What does it take to get a reporter interested in your story? This is the key to getting covered in today’s environment. Your story needs to do more than just “add noise” and must provide value to their audiences. Also, reporters are competing with bloggers, social influencers and others who are pushing out information quicker than the media, so the speed at which you can get them information could decide whether or not your story runs – reporters have less time to get their stories right, so providing them with immediate access to what they need is critical.

    Channeling The Patient Voice. Now more than ever the consumer voice is heard and it’s making a difference. It seems that everyone wants to hear from real people, and patient influencers can humanize your story and help you get your messages out. However, they are only effective if they are seen as credible and genuine, so maintaining the trust of their communities is critical.

    Telling the Customer Story. Times have changed, healthcare has become very personal, and the brand is no longer at the center of the universe, and new approaches are needed to reach audiences. One approach is through brand storytelling, and the key here is finding ways to inspire through stories. However, the story is about the customer, and the brand is just a plot point in their story. It’s not about what you’re selling, but how what you’re selling ties into your customer’s story.

    Changes within the newsroom show no signs of slowing down and, as communicators, we will continue to adapt to these changes and find new ways to break through our messages to benefit the patients we serve. It will certainly be interesting to see where things head in the years to come.

  • May 10, 2017
    • Comments Off on A Good Decision for American Healthcare and Patients

    A Good Decision for American Healthcare and Patients

    This blog post by Craig Heit

    Yesterday, the Senate confirmed Dr. Scott Gottlieb as Commissioner of the U.S. Food & Drug Administration. I believe this is very good news for patients anxiously awaiting more answers to their pressing health needs. I worked with Scott early in his career, and am confident that he has the experience, the intellect and the temperament to focus the agency on its core responsibilities, while addressing many of the challenges we face healthcare today. I believe he will make a difference.

    Challenges? There are a lot of them, from the speed of getting life-saving and life-changing medicines to market, to access to drugs, to the huge amounts of information readily available to patients and other consumers that barely existed just 10 years ago. The FDA can’t fix everything that’s problematic with the healthcare system today, but it can have a big impact on many issues.

    Opportunities? One thing I believe about Scott is that at the root of his beliefs is that what matters to patients is what matters most. I don’t have a crystal ball, but I do think we’ll begin to see a much greater focus at the Agency on patient-centered activities that are authentic and will have impact now and in the future.

    Having worked at the FDA, Scott understands the organization – both what it does well and where it needs work. He understands that the Agency’s risk assessment skills are unparalleled, and need to be focused. As he said in a speech before the International Society for Stem Cell Research: “The FDA need to focus on those areas that create the most potential for risk, and channel its resource behind those efforts. Right now, FDA is often too easily distracted by attractive areas like iPhone apps that nonetheless pose relatively low risks and could be ably addressed by other regulatory agencies.”

    The search for absolute statistical certainty for the risks and benefits of new drugs has stalled much progress in new drug development. I think we should expect more use of readily available new tools – related to trial design and statistical analysis – to tighten up the approval process for potentially life-saving drugs.

    The FDA plays a critical role in assessing the safety and granting approval of potentially life-saving (or at least life-changing) drugs. Under Dr. Gottlieb’s leadership, I believe patients will see the Agency become a welcome partner in the efficient and effective pursuit of safe and valuable treatments. I respect, admire and trust Scott, and he has my “vote” to do many needed and different actions for the American healthcare system and, most particularly, for the patients anxiously awaiting these innovative drugs and devices to become available.

Page 1 of 9123Last